Specialty Pharmacies and Vaccines

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Pharmacy Times

JUNE 20, 2025

Expanding use of the 15-valent pneumococcal conjugate vaccine (PCV15) or 20-valent pneumococcal conjugate vaccine (PCV20) to all United States adults aged 50 to 64 years would result in modest budget increases over a 3-year period. 1,2 A particular disease burden is present for Black Americans.

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Pharmacy Times

JUNE 12, 2025

The introduction of the human papillomavirus (HPV) vaccine marked a major turning point, contributing to nearly a 50% reduction in incidence rates and a 70% decrease in mortality since the 1950s.

Vaccines

Vaccines Pharmacy Technician Immunity Immunization

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

Pharmacy Times

JUNE 8, 2025

Within this expansive network, the neurology clinical pharmacy specialist serves a vital dual role. The position ensures continuous care coordination and medication oversight across the system’s specialty pharmacy and neurology practices. 1 Evidence from recent studies supports the effectiveness of this approach.

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Trending Sources

Specialty Pharmacist Integration in Neurology Clinics: A Model for Enhanced Patient Care

Amber Specialty Pharmacy Selected To Dispense NEMLUVIO® (nemolizumab-ilto) by Galderma for Prurigo Nodularis

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

Study Shows High-Dose Vitamin D Boosts Treatment Response in Breast Cancer

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Pharmacists Reimagine Myeloma Care With Insights from ASCO

OTC Assessments With Recommendations and Counseling Should Be a Billable Encounter

10 Opportunities to Leverage for Career Advancement

McKesson Corporation Completes Acquisition of Core Ventures

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations

Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy

Collaborative Management of Severe Pericarditis: The Role of Pharmacists in Rilonacept Treatment

OTC Case Studies: Summer Skin Care

Nitisinone Becomes First and Only FDA-Approved Treatment for HGA in Adults With AKU

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Available for Preorder: The 2022 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

Inside the Synergy Between HOPA and OPC’s Evolving Educational Impact

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

ADA 2025: CagriSema Demonstrates Significant Weight Loss in REDEFINE Clinical Trials

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults

FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Impact of Patient Access to Care on Rates of Febrile Neutropenia Post Inpatient Administration of a Colony-Stimulating Factor

New Online Competency Modules Standardize CPA Pharmacist Training at Academic Medical Center

ADA 2025: Ready-to-Use Glucagon Empowers Diabetes Patient Safety

ADA 2025: Advances in Type 2 Diabetes Management With Tirzepatide

FDA Approves Tablet Formulation of Zanubrutinib for All Indications

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Overweight, Obesity Associated With Neurologic and Neuropsychiatric Symptoms in Post-COVID-19 Condition

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

Real-World Data on Expanding Step-Up Dosing Administration of Bispecific T-Cell Engagers in the Outpatient Setting

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Walgreens Launches Program to Enable Technicians to Pursue Pharmacy School

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Immunotherapy Takes the Lead in Advanced Cutaneous Malignancies

FDA Approves Datopotamab for Treatment of EGFR-Mutated Non-Small Cell Lung Cancer

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Stay Connected